Company intelligence / Profile preview

Symbiosis Pharmaceutical Services

Stirling, Scotland, United Kingdom

Ownership: Private
Employees: ~112
Development stage: Other

Overview

Symbiosis does not itself develop clinical drug products but provides GMP manufacturing for client drugs ranging from pre-clinical through commercial stages and has supported hundreds of clinical trial and niche commercial supply projects.

Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateViral vectorPeptidesRNA therapyRecombinant proteinATMP (Advanced Therapy Medicinal Product)
Industry: Contract Manufacturing Organization

Partnerships

AstraZeneca (COVID-19 vaccine supply agreement)

Beyond the preview

Go deeper on Symbiosis Pharmaceutical Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symbiosis Pharmaceutical Services.

Explore the full profile